Fabrication and characterization of bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked by glutaraldehyde for bone regeneration

Abstract

Objectives Alendronate are widely used in the treatment of bone disorders characterized by inhibit osteoclast-mediated bone resorption such as Paget’s disease, fibrous dysplasia, myeloma, bone metastases and osteoporosis. In recent studies alendronate improves proliferation and differentiation of osteoblasts, thereby facilitating for bone regeneration. The disadvantages of this class are their poor bioavailability and side effects on oral and intravenous application such as stomach irritation and osteonecrosis in jaw. Thus, local treatment of alendronate is needed in order to achieve high concentration of drug. Bovine hydroxyapatite-gelatin scaffold with alendronate was studied. Glutaraldehyde was used as cross-linking agent, increase the characteristics of this scaffold. The objectives of this study were to manufacture and characterize alendronate scaffold using bovine hydroxyapatite-gelatin and crosslinked by glutaraldehyde. Methods Preparation of cross-linked bovine hydroxyapatite-gelatin and alendronate scaffold with different concentration of glutaraldehyde (0.00, 0.50, 0.75, and 1.00%). The scaffolds were characterized for compressive strength, porosity, density, swelling ratio, in vitro degradation, and cytotoxicity (the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assay, shorted as MTT assay). Results Bovine hydroxyapatite-gelatin-alendronate scaffold cross-linked with glutaraldehyde showed lower density than without glutaraldehyde. As glutaraldehyde concentration increased, porosity also increased. Eventually, it reduced compressive strength. Swelling ratio and in vitro degradation was negatively dependent on glutaraldehyde concentration. In addition, the scaffold has a good safety by MTT assay. Conclusions Bovine hydroxyapatite-gelatin-alendronate scaffold was fabricated with various concentrations of glutaraldehyde. The presence of glutaraldehyde on bovine hydroxyapatite-gelatin-alendronate is safe and suitable candidate scaffold for bone regeneration.

Osteogenic differentiation and proliferation potentials of human bone marrow and umbilical cord-derived mesenchymal stem cells on the 3D-printed hydroxyapatite scaffolds

“…Bone grafting using hydroxyapatite results in direct chemical bonding of hydroxyapatite to the bone 56 . Hydroxyapatite is used as a single material or in combination with other materials, such as a coating agent for bone graft 57 and a matrix for drug delivery systems targeting bone tissue repair 58 . A customized scaffold with the desirable anatomical contour can be manufactured via 3D printing as the technique allows simple, fast, accurate, and several tests to be conducted on the biomaterial.…”

Application of Biomedical Microspheres in Wound Healing

“…Gelatin is a water-soluble biodegradable polymer that belongs to the hydrolysate of collagen, and it has a variety of bioactive motifs including arginine–glycine–aspartate (RGD) [ 107 , 108 ]. Generally, gelatin microspheres are prepared by the chemical crosslinking method, and glutaraldehyde is a common reagent for protein crosslinking, which can be used for the crosslinking preparation of gelatin microspheres [ 109 , 110 ]. Gelatin solution concentration is one of the vital parameters to affect the diameter and morphology of microspheres.…”

A novel gelatin/carboxymethyl chitosan/nano-hydroxyapatite/β-tricalcium phosphate biomimetic nanocomposite scaffold for bone tissue engineering applications

“…Additionally, the scaffold must allow for the migration and growth of cells to maintain a stable structure ( Noor, 2013 ). To address this issue, many researchers use natural degradable materials, such as gelatin or hyaluronic acid ( Catalan et al, 2019 ; Nabavinia et al, 2019 ; Samirah et al, 2021 ; Xu et al, 2021 ). It is common to use organic compounds with nano-HA to form three-component scaffolds such as gelatin/chitosan/nano-HA scaffolds ( Filippi et al, 2020 ).…”